NCT07568132
Efferon LPS Hemoadsorption in in Patients With Thermal Burns
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Recruitment opened Show 4 more changesShow less
- Start date changed from estimate of May 15, 2026 to Oct 21, 2026
- Eligibility criteria expanded, about 13 words
- Secondary endpoints: details revised at 2 of 7 entries
- Site details revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Need for vasopressor support
Timeframe: 1-28 days
Secondary (7)
Horowitz oxygenation index
Renal replacement therapy (RRT) free days
28 and 60 days mortality
Length of stay in the intensive care unit
Duration of hospitalization
Show 2 moreShow less
Frequency of septic complications
Frequency of surgical interventions
Arms and interventions
Baseline therapyNo intervention
Patients receiving standard treatment for the treatment of thermal burns without the use of hemoadsorption methods, but who are prescribed continuous renal replacement therapy (CRRT) for renal and non-renal indications.
Baseline therapy + Efferon LPSExperimental
Patients receiving standard therapy for the treatment of thermal burns, along with Efferon LPS hemoadsorption procedures in combination with continuous renal replacement therapy (CRRT).
Devices: Efferon LPS
Sites
1 site in 1 country
- N.V. Sklifosovsky Research Institute for Emergency MedicineMoscow, Russia